Assessment of Potential Efficacy of Coliphage Therapy on Multidrug Resistant Clinical Isolates of Escherichia coli

Authors

  • Sulaiman, M. A. Department of Microbiology, Faculty of Life Sciences, Ahmadu Bello University, Zaria.
  • Usman, A.R. Department of Microbiology, Faculty of Life Sciences, Ahmadu Bello University, Zaria.

DOI:

https://doi.org/10.47430/ujmr.2051.008

Keywords:

Bacteriophage, Coliphage, Multidrug Resistance, Cytopathic effect

Abstract

Coliphages are the bacteriophage that attack and lyse Escherichia coli, a bacterium emerging as multidrug resistant, thereby posing serious public health challenge. Thus, searching for alternative therapies, one of which is coliphage therapy is timely. The work was aimed at screening clinical isolates of E. coli for the ability to host the coliphage and to determine the cytopathic effect of the coliphages against the multidrug resistant E. coli hosts. Eight (8) clinical isolates of E. coli were reconfirmed using both conventional and PCR techniques. The isolates were used for the detection and enumeration of the coliphage. The lowest plaque forming unit (PFU/µL) dilution of each of the 5 samples collected, was determined using double agar overlay method. The isolates that successfully hosted the growth of the phage were further screened against 8 commonly used antibiotics, using disc diffusion method. Out of the 8 clinical isolates collected, 5(62.5%) were confirmed as E coli, out of which 3 (60%) supported the growth of the coliphage. The lowest PFU dilution was 1:108 and all the 3  isolates of E. coli that supported the growth of the coliphages were found to be Multi Drug Resistant (MDR) and were all (100%) lysed by the coliphages. Phage therapy was found to be effective against even the MDR bacteria as such, can be considered an alternative therapy. However, a cocktail of the phages may be necessary to ensure absolute adsorption and successful lysis of the pathogens.

Downloads

Download data is not yet available.

References

Calap, P.D. and Martinez, D.F. (2018). Bacteriophages: Protagonist of a Post Antibiotic Era. Antibiotics,7(66):2-5

https://doi.org/10.3390/antibiotics7030066

Cheesebrough M. (2009). District Laboratory Practice in Tropical Countries. Cambridge University Press, 2nd ed., 96- 97.

Delmas, J., Dalmasso, G. and Bonnet, R. (2015). Escherichia coli: The Good, the Bad and theUgly. Clinical Microbiology,4(2):195-198.Haq, I., Chaudhry, W.N., Akhtar, M.N., Andleeb, S. and Qadri,I. (2012). Bacteriophages and their implications on future biotechnology. Virology Journal,9(9):1-3

https://doi.org/10.1186/1743-422X-9-9

Igwe, J.C., Olayinka, B.O., Ehnimidu, J.O. and Onaolapo, J.A. (2016). VirulentCharacteristics of Multidrug Resistant E. coli from Zaria, Nigeria.Clinical Microbiology 5(6): 268.doi:10.4172/2327 5073.1000268

Lin, D.M., Koskella, B. and Lin, H.C. (2017). Phage therapy: An alternative to antibiotics in the age of multi-drug resistance. World Journal of Gastrointestinal Pharmacology and Therapeutics.8(3):162-173.

https://doi.org/10.1093/ptj/pzx090

Lindsey, R.L., Garcia-Toledo, L., Fasulo D., Gladney, L.M. and Strockbine N. (2017). Multiplex polymerase chain reaction for identification of Escherichia coli, Escherichia albertii and Escherichiafergusonii. Journal of Microbiology Methods,140: 1-4.

https://doi.org/10.1016/j.mimet.2017.06.005

Morozova V.V., Vlassov V.V. and Tikunova N.V. (2018) Applications of Bacteriophages in the Treatment of Localized Infections in Humans. Frontiers in Microbiology9:1696.doi:10.3389/fmicb. 2018.01696

https://doi.org/10.3389/fmicb.2018.01696

Orlova, E.V. (2012). Bacteriophages and Their Structural Organisation. Bacteriophages. Dr. Ipek Kurtboke (Ed.), ISBN: 978 953-51-0272-4

https://doi.org/10.5772/34642

Parfitt, T. (2005). Georgia: an unlikely stronghold for bacteriophage therapy. Lancet. 365(9478):2166-2167.

https://doi.org/10.1016/S0140-6736(05)66759-1

Pallavali, R.R., Degati, V. L., Lomada, D., Reddy, M.C. and Durbaka, V.R.P. (2017). Isolation and In vitro evaluation of bacteriophages against MDR- bacterial isolates fromsepticwound infections. PLoSONE. 12(7): e0179245.https://doi.org/10.1371/jour nal.pone.0179245

https://doi.org/10.1371/journal.pone.0179245

Principi, N., Silvestri, E. and Esposito, S. (2019). Advantages and limitations of Bacteriophages for the treatment of bacterial infections.Frontiers in Pharmacology. https://doi.org/10.33091/fphar.201900 513

https://doi.org/10.3389/fphar.2019.00513

Salmond, G.P.C. and Fineran, P.C. (2015). A Century of the Phage: Past,Present and Future.Nature reviews/Microbiology. Macmillan Publishers limited 13: 777-785

https://doi.org/10.1038/nrmicro3564

Santos, S.B., Carvalho, C.M. and Sillankorva, S. (2009). The use of antibiotics toimprove phage detection and innumeration by the double layer agar technique.BMC Microbiology,9:148-157

https://doi.org/10.1186/1471-2180-9-148

Sarker, S.A., Sultana, S., Reuteler, G., Moine, D., Descombes, P. and Charton, F. (2016). Oral Phage Therapy of Acute Bacterial with Two Coliphage Preparation: A Randomized Trial in Children from Bangladesh. EBio Medicine,4:124-137

https://doi.org/10.1016/j.ebiom.2015.12.023

Sulakvelidze, A. (2011). Bacteriophage: the most ubiquitous organisms on earth. Bacteriophage.1:1-2.Doi:10.4161/bact.1.15030

https://doi.org/10.4161/bact.1.1.15030

Sulakvelidze, A., Zamphira, A. and Glenn, M.J. (2001). Bacteriophage Therapy. Antimicrobial Agents and Chemotherapy,45(3):649-659

https://doi.org/10.1128/AAC.45.3.649-659.2001

Wayne, P.A (2018). Performance Standards for Antimicrobial Susceptibility Testing.28thed. CLSI supplement M100. Clinical and Laboratory Standards Institute

Withey, S., Cartmell, E., Avery, L.M. and Stephenson, T. (2005). Bacteriophages Potential for application in waste water treatment processes. Science of the total environment, 339 (1-3):1-18

https://doi.org/10.1016/j.scitotenv.2004.09.021

Wok, G. (2001). Bacteriophage: Update on application as models for viruses in water.Water SA, 27(2):251-268

World Health Organization (2014). Antimicrobial Resistance Global Report on Surveillance. ISBN 978 92 4 1564748.

Downloads

Published

30-06-2020

How to Cite

Sulaiman, M. A., & Usman, A.R. (2020). Assessment of Potential Efficacy of Coliphage Therapy on Multidrug Resistant Clinical Isolates of Escherichia coli. UMYU Journal of Microbiology Research (UJMR), 5(1), 49–53. https://doi.org/10.47430/ujmr.2051.008